Parametric Investigation into the Shear Strength of Adhesively Bonded Single-Lap Joints.

In this paper, the shear strength of adhesively bonded single-lap joints were experimentally and numerically investigated. Based on the validated simulation, the effects of lap length, adhesive layer thickness, adhesive layer shape, adhesive layer overflow length, and laminate lay-up on the shear strength of adhesively bonded single-lap joints were studied. The load-displacement curves and shear strength under different parameters were compared. It was shown that the shear strength of single-lap joints gradually decreases with the increase of lap length and adhesive layer thickness, which were 53.83% and 16.15%, respectively. Considering the potential condition in fabrication, the adhesive layer shape and adhesive layer overflow length were also investigated. The adhesive with normal and triangle shape owned the comparable shear strength, which was higher than the arc one. The shear strength increased by 19.37% from 18.43 MPa to 22.00 MPa with increasing the adhesive layer overflow length to 50% of lap length. It was beneficial for shear strength to increase the adhesive layer overflow length to 50% of lap length. Among the selected four lay-ups, [0]16s had the highest shear strength, which was nearly 3 times greater than the one of [90]16s. In the real process preparation, increasing the number of 0° layers, selecting the appropriate lap length and thickness of the adhesive layer, and controlling the shape and length of the adhesive layer overflow are of great help to improve the tensile shear strength of the single-lap glue joint.

Sirtuin 5: a review of structure, known inhibitors and clues for developing new inhibitors.

Sirtuins (SIRTs) are nicotinamide adenine dinucleotide (NAD+)-dependent protein deacetylases, which regulate important biological processes ranging from apoptosis, age-associated pathophysiologies, adipocyte and muscle differentiation, and energy expenditure to gluconeogenesis. Very recently, sirtuin 5 (SIRT5) has received considerable attention due to that it was found to have weak deacetylase activity but strong desuccinylase, demalonylase and deglutarylase activities, and it was also found to be associated with several human diseases such as cancer, Alzheimer's disease, and Parkinson's disease. In this review, we for the first time summarized the structure characteristics, known peptide and smallmolecule inhibitors of SIRT5, extracted some clues from current available information and introduced some feasible, practical in silico methods, which might be useful in further efforts to develop new SIRT5 inhibitors.